Thomas Lategan
General Counsel bei BRIGHT MINDS BIOSCIENCES INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ian McDonald | M | 37 | 5 Jahre | |
| Jeremy Fryzuk | M | 39 | 4 Jahre | |
| Nils Bottler | M | 37 | 4 Jahre | |
| Jan Pedersen | M | 59 | 2 Jahre | |
| Ryan Cheung | M | 45 | 4 Jahre | |
| David Weiner | M | 59 | 1 Jahre | |
| Mark A. Smith | M | 68 | 2 Jahre | |
| Gideon Shapiro | M | 64 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Lawrence Bloch | M | 58 |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | 4 Jahre |
| Alan Kozikowski | M | 74 | 3 Jahre | |
| Robert A. Medv | M | 58 |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | 5 Jahre |
| Eugenia Rutenberg | F | - |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 9 Jahre |
| Emer Leahy | M | 58 | 1 Jahre | |
| Jane Henderson | F | 58 | 1 Jahre | |
| Fred M. Ryan | M | 72 | 5 Jahre | |
| Douglas Williamson | M | 61 | 1 Jahre | |
| Peyton J. Marshall | M | 69 | 2 Jahre | |
| Armin M. Kessler | M | 85 | - | |
| Sam Wertheimer | M | 63 |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | 3 Jahre |
| Shalom Jacobovitz | M | 63 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 10 Jahre |
| Jane Wright-Mitchell | F | 55 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 3 Jahre |
| Herb H. Hooper | M | 60 | - | |
| Jean-Marc Bellemin | M | 51 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 15 Jahre |
| Lee Golden | M | 56 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 3 Jahre |
| Miri Wernli | M | 71 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 9 Jahre |
| E. Blair Clark-Schoeb | F | - | 2 Jahre | |
| Stacy Markel | F | 59 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 13 Jahre |
| Ran Frenkel | M | 55 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 3 Jahre |
| Rajiv Patni | M | 55 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 7 Jahre |
| Eric Linsley | M | 62 | 2 Jahre | |
| Christina Willwerth | F | 53 | 2 Jahre | |
| Revati Shreeniwas | M | 63 | 2 Jahre | |
| Robert G. Savage | M | 70 | 2 Jahre | |
| Simon Buckingham | M | 60 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | 5 Jahre |
| Jules S. Jacob | M | - | 1 Jahre | |
| Robert Yedid | M | 66 | 2 Jahre | |
| John Richards | M | 67 | - | |
| Fazle Husain | M | 60 | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 35 | 92,11% |
| Kanada | 3 | 7,89% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thomas Lategan
- Persönliches Netzwerk
